


Searching News Database: IMS Health
HSMN NewsFeed - 30 Jun 2020
ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules
ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules
HSMN NewsFeed - 27 Jun 2018
ANI Pharmaceuticals Announces Launch of Cholestyramine for Oral Suspension USP
ANI Pharmaceuticals Announces Launch of Cholestyramine for Oral Suspension USP
HSMN NewsFeed - 7 May 2018
ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax
ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax
HSMN NewsFeed - 14 Feb 2018
Teligent, Inc. Announces FDA Approval of Betamethasone Dipropionate Lotion USP (Augmented), 0.05%
Teligent, Inc. Announces FDA Approval of Betamethasone Dipropionate Lotion USP (Augmented), 0.05%
HSMN NewsFeed - 24 Jan 2018
Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace(R) Cream
Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace(R) Cream
HSMN NewsFeed - 24 Jan 2018
Perrigo Announces Final FDA Approval And Launch Of An AB Rated Generic Version Of Epiduo(R) Gel
Perrigo Announces Final FDA Approval And Launch Of An AB Rated Generic Version Of Epiduo(R) Gel
HSMN NewsFeed - 26 Dec 2017
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
HSMN NewsFeed - 28 Nov 2017
Upsher-Smith Launches KLOR-CON(R) Powder (Potassium Chloride) For Oral Solution
Upsher-Smith Launches KLOR-CON(R) Powder (Potassium Chloride) For Oral Solution
HSMN NewsFeed - 11 Oct 2017
Upsher-Smith Launches Generic Version Of Aromasin(R) (Exemestane) Tablets
Upsher-Smith Launches Generic Version Of Aromasin(R) (Exemestane) Tablets
HSMN NewsFeed - 1 Sep 2017
ANI Pharmaceuticals Announces Approval and Launch of Oxycodone Hydrochloride Oral Solution, 100 mg/5mL
ANI Pharmaceuticals Announces Approval and Launch of Oxycodone Hydrochloride Oral Solution, 100 mg/5mL
HSMN NewsFeed - 21 Jul 2017
Teligent, Inc. Announces FDA Approval Of Erythromycin Topical Gel USP, 2%
Teligent, Inc. Announces FDA Approval Of Erythromycin Topical Gel USP, 2%
HSMN NewsFeed - 20 Jun 2017
ANI Pharmaceuticals Announces Launch of Diphenoxylate HCl and Atropine Sulfate Tablets
ANI Pharmaceuticals Announces Launch of Diphenoxylate HCl and Atropine Sulfate Tablets
HSMN NewsFeed - 26 Apr 2017
Impax Announces FDA Approval and Launch of a Generic Version of Vytorin(R) (Ezetimibe/Simvastatin Tablets)
Impax Announces FDA Approval and Launch of a Generic Version of Vytorin(R) (Ezetimibe/Simvastatin Tablets)
HSMN NewsFeed - 22 Feb 2017
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
HSMN NewsFeed - 27 Sep 2016
Upsher-Smith Enters into Exclusive Development and Distribution Agreement with Pharmathen S.A.
Upsher-Smith Enters into Exclusive Development and Distribution Agreement with Pharmathen S.A.
HSMN NewsFeed - 8 Jul 2016
Teligent, Inc. Receives Two FDA Approvals for Topical Prescription Portfolio
Teligent, Inc. Receives Two FDA Approvals for Topical Prescription Portfolio
HSMN NewsFeed - 14 Jun 2016
Nephron Pharmaceuticals Corporation Launches Generic Budesonide Inhalation Suspension
Nephron Pharmaceuticals Corporation Launches Generic Budesonide Inhalation Suspension
HSMN NewsFeed - 2 May 2016
Allergan Receives FDA Approval and Launches First Generic Version of CRESTOR(R) (rosuvastatin)
Allergan Receives FDA Approval and Launches First Generic Version of CRESTOR(R) (rosuvastatin)
HSMN NewsFeed - 29 Feb 2016
Allergan Announces Receipt Of FDA Acceptable For Filing Letter For Generic XIFAXAN(R) ANDA
Allergan Announces Receipt Of FDA Acceptable For Filing Letter For Generic XIFAXAN(R) ANDA
HSMN NewsFeed - 19 Jan 2016
Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection
Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection
HSMN NewsFeed - 5 Nov 2015
Lupin Appoints Thierry Volle as President - Europe, Middle-East & Africa (EMEA)
Lupin Appoints Thierry Volle as President - Europe, Middle-East & Africa (EMEA)
HSMN NewsFeed - 17 Sep 2015
Impax Receives FDA Approval for Generic Version of Mestinon(R) Timespan(R) Tablets, 180 mg
Impax Receives FDA Approval for Generic Version of Mestinon(R) Timespan(R) Tablets, 180 mg
HSMN NewsFeed - 20 Apr 2015
Oasmia's Lead Cancer Product Paclical(R) Receives Market Approval in the Russian Federation
Oasmia's Lead Cancer Product Paclical(R) Receives Market Approval in the Russian Federation
HSMN NewsFeed - 25 Sep 2014
IGI Laboratories, Inc. Acquires Eighteen Former Products From AstraZeneca
IGI Laboratories, Inc. Acquires Eighteen Former Products From AstraZeneca
HSMN NewsFeed - 10 Sep 2014
Mylan to Acquire U.S. Rights to Arixtra(R) (fondaparinux sodium) Injection from Aspen
Mylan to Acquire U.S. Rights to Arixtra(R) (fondaparinux sodium) Injection from Aspen
HSMN NewsFeed - 19 Dec 2013
Cancer Genetics, Inc. Strengthens Its Diagnostics Sales Team With Seasoned Industry Leader
Cancer Genetics, Inc. Strengthens Its Diagnostics Sales Team With Seasoned Industry Leader
HSMN NewsFeed - 21 Nov 2013
Impax Laboratories Launches Generic Solaraze(R) (Diclofenac Sodium Gel, 3%)
Impax Laboratories Launches Generic Solaraze(R) (Diclofenac Sodium Gel, 3%)
HSMN NewsFeed - 13 Mar 2013
Covidien Launches Three New Hernia Care Products at American Hernia Society Annual Meeting
Covidien Launches Three New Hernia Care Products at American Hernia Society Annual Meeting
HSMN NewsFeed - 22 Feb 2013
Lupin Receives FDA Approval for New Drug Application for SUPRAX(R) Oral Suspension, 500 mg/5mL
Lupin Receives FDA Approval for New Drug Application for SUPRAX(R) Oral Suspension, 500 mg/5mL
HSMN NewsFeed - 6 Feb 2013
Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Naltrexone
Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Naltrexone
HSMN NewsFeed - 7 Sep 2012
Mylan Announces Settlement Agreement in Litigation Relating to Detrol(R) LA
Mylan Announces Settlement Agreement in Litigation Relating to Detrol(R) LA
HSMN NewsFeed - 22 Aug 2012
Wockhardt receives tentative US FDA approval for generic version of anti-psychotic drug Geodon(R)
Wockhardt receives tentative US FDA approval for generic version of anti-psychotic drug Geodon(R)
HSMN NewsFeed - 26 Jan 2012
Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Hydromorphone
Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Hydromorphone
HSMN NewsFeed - 23 Dec 2011
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity
HSMN NewsFeed - 21 Nov 2011
Mylan Announces Settlement Agreement for its First-to-File Generic Version of Vivelle-Dot(R)
Mylan Announces Settlement Agreement for its First-to-File Generic Version of Vivelle-Dot(R)
HSMN NewsFeed - 5 Aug 2011
Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
HSMN NewsFeed - 28 Jan 2011
Mylan Receives Approval for First-to-File Generic Sular(R) Extended-Release Tablets
Mylan Receives Approval for First-to-File Generic Sular(R) Extended-Release Tablets
HSMN NewsFeed - 24 Jan 2011
Mylan's Matrix Receives Approval for Generic Version of Protonix(R) Delayed-release Tablets
Mylan's Matrix Receives Approval for Generic Version of Protonix(R) Delayed-release Tablets
HSMN NewsFeed - 24 Jan 2011
Clinical Data, Inc. Announces FDA Approval of Viibryd(TM) (vilazodone HCl) for Major Depressive Disorder
Clinical Data, Inc. Announces FDA Approval of Viibryd(TM) (vilazodone HCl) for Major Depressive Disorder
HSMN NewsFeed - 30 Oct 2010
APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP
APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP
HSMN NewsFeed - 21 Jun 2010
APP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USP
APP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USP
HSMN NewsFeed - 21 Apr 2010
Akorn Announces FDA Approval to Re-Launch Erythromycin Ophthalmic Ointment USP 3.5 g
Akorn Announces FDA Approval to Re-Launch Erythromycin Ophthalmic Ointment USP 3.5 g
HSMN NewsFeed - 19 Apr 2010
Mylan Announces Approval Under PEPFAR for Generic Version of Videx(R) EC HIV Treatment
Mylan Announces Approval Under PEPFAR for Generic Version of Videx(R) EC HIV Treatment
HSMN NewsFeed - 15 Mar 2010
Ranbaxy Announces Settlement of Actos(R) (Pioglitazone Hydrochloride) Patent Litigation
Ranbaxy Announces Settlement of Actos(R) (Pioglitazone Hydrochloride) Patent Litigation
HSMN NewsFeed - 11 Jan 2010
Mylan Confirms First-to-File Patent Challenge Relating to Sleep-Disorder Drug Nuvigil(R)
Mylan Confirms First-to-File Patent Challenge Relating to Sleep-Disorder Drug Nuvigil(R)
HSMN NewsFeed - 8 Dec 2009
Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
HSMN NewsFeed - 15 Oct 2009
Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
HSMN NewsFeed - 30 Sep 2009
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Sinemet(R)
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Sinemet(R)
HSMN NewsFeed - 27 Aug 2009
Mylan Begins Marketing First Generic Version of BenzaClin(R) Acne Treatment
Mylan Begins Marketing First Generic Version of BenzaClin(R) Acne Treatment
HSMN NewsFeed - 18 Aug 2009
Par Pharmaceutical & Aveva Drug Delivery Systems Receive Final Approval to Market Generic Catapres TTS(R)
Par Pharmaceutical & Aveva Drug Delivery Systems Receive Final Approval to Market Generic Catapres TTS(R)
HSMN NewsFeed - 20 Jul 2009
Mylan Receives FDA Approval for Additional Strengths of the Antipsychotic Haloperidol
Mylan Receives FDA Approval for Additional Strengths of the Antipsychotic Haloperidol
HSMN NewsFeed - 16 Jul 2009
Mylan Receives FDA Approval for Generic Version of Thyroid Deficiency Treatment Cytomel(R)
Mylan Receives FDA Approval for Generic Version of Thyroid Deficiency Treatment Cytomel(R)
HSMN NewsFeed - 7 Jul 2009
Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)
Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)
HSMN NewsFeed - 17 Jun 2009
Mylan Receives FDA Approval for Additional Strength of Generic Restoril(R)
Mylan Receives FDA Approval for Additional Strength of Generic Restoril(R)
HSMN NewsFeed - 2 Jun 2009
Clinical Data, Inc. Announces Positive Results from Second Phase III Trial of Vilazodone for Depression
Clinical Data, Inc. Announces Positive Results from Second Phase III Trial of Vilazodone for Depression
HSMN NewsFeed - 29 May 2009
Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)
Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)
HSMN NewsFeed - 13 May 2009
AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure
AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure
HSMN NewsFeed - 14 Apr 2009
Mylan Confirms First-to-File Patent Challenge Relating to Xeloda(R) Cancer Treatment
Mylan Confirms First-to-File Patent Challenge Relating to Xeloda(R) Cancer Treatment
HSMN NewsFeed - 28 Jan 2009
Mylan Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD
Mylan Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD
HSMN NewsFeed - 23 Jan 2009
Mylan Receives Final FDA Approval for Generic Version of Prilosec(R) Delayed-Release Capsules, 40 mg
Mylan Receives Final FDA Approval for Generic Version of Prilosec(R) Delayed-Release Capsules, 40 mg
HSMN NewsFeed - 30 Dec 2008
Mylan's Matrix Receives Final FDA Approval for the Generic Version of the Antiretroviral Zerit(R) Capsules
Mylan's Matrix Receives Final FDA Approval for the Generic Version of the Antiretroviral Zerit(R) Capsules
HSMN NewsFeed - 29 Dec 2008
Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)
Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)
HSMN NewsFeed - 17 Nov 2008
Mylan Receives Tentative FDA Approval for the Generic Version of the Antidepressant Effexor XR(R)
Mylan Receives Tentative FDA Approval for the Generic Version of the Antidepressant Effexor XR(R)
HSMN NewsFeed - 29 Oct 2008
FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
HSMN NewsFeed - 22 Sep 2008
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Parcopa(R) ODT
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Parcopa(R) ODT
HSMN NewsFeed - 16 Sep 2008
Mylan Receives FDA Approval for Generic Version of Anti-Psychotic Risperdal(R)
Mylan Receives FDA Approval for Generic Version of Anti-Psychotic Risperdal(R)
HSMN NewsFeed - 3 Jul 2008
Mylan Announces Tentative FDA Approval for Generic Version of Antibiotic Zyvox(R) Tablets
Mylan Announces Tentative FDA Approval for Generic Version of Antibiotic Zyvox(R) Tablets
HSMN NewsFeed - 16 Jun 2008
Mylan Announces Tentative FDA Approval for Generic Version of Antihypertensive Avalide(R) Tablets
Mylan Announces Tentative FDA Approval for Generic Version of Antihypertensive Avalide(R) Tablets
HSMN NewsFeed - 3 Jun 2008
Watson Receives FDA Approval of Potassium Chloride Extended-Release Capsules
Watson Receives FDA Approval of Potassium Chloride Extended-Release Capsules
HSMN NewsFeed - 7 May 2008
Par Pharmaceutical Acquires Spectrum Pharmaceutical's Interest In Sumatriptan Injection
Par Pharmaceutical Acquires Spectrum Pharmaceutical's Interest In Sumatriptan Injection
HSMN NewsFeed - 21 Apr 2008
Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
HSMN NewsFeed - 28 Mar 2008
Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S.
Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S.
HSMN NewsFeed - 13 Mar 2008
Sciele Pharma Acquires Twinject(R) Epinephrine Auto-Injector from Verus Pharmaceuticals
Sciele Pharma Acquires Twinject(R) Epinephrine Auto-Injector from Verus Pharmaceuticals
HSMN NewsFeed - 19 Feb 2008
Santarus Announces Launch of ZEGERID Products by GlaxoSmithKline in Puerto Rico and U.S. Virgin Islands
Santarus Announces Launch of ZEGERID Products by GlaxoSmithKline in Puerto Rico and U.S. Virgin Islands
HSMN NewsFeed - 24 Jan 2008
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
HSMN NewsFeed - 4 Jan 2008
IMS Health Announces Restructuring Actions to Improve Operating Efficiencies, Address Client Priorities
IMS Health Announces Restructuring Actions to Improve Operating Efficiencies, Address Client Priorities
HSMN NewsFeed - 31 Oct 2007
Javelin Pharmaceuticals Receives Marketing Authorization Approval for Dyloject(R) in the United Kingdom
Javelin Pharmaceuticals Receives Marketing Authorization Approval for Dyloject(R) in the United Kingdom
HSMN NewsFeed - 15 Aug 2007
Collegium Pharmaceutical Provides Update on Development of its Nasal Inhaled Steroid for Allergic Rhinitis
Collegium Pharmaceutical Provides Update on Development of its Nasal Inhaled Steroid for Allergic Rhinitis
HSMN NewsFeed - 16 Jul 2007
Sciele Pharma Acquires a Novel, Patented Treatment for Head Lice from Summers Laboratories, Inc.
Sciele Pharma Acquires a Novel, Patented Treatment for Head Lice from Summers Laboratories, Inc.
HSMN NewsFeed - 12 Jul 2007
Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals to Market CLONICEL(R)
Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals to Market CLONICEL(R)
HSMN NewsFeed - 22 May 2007
Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
HSMN NewsFeed - 1 May 2007
New Hampshire Law Banning Commercial Use of Prescription Information Declared Unconstitutional
New Hampshire Law Banning Commercial Use of Prescription Information Declared Unconstitutional
HSMN NewsFeed - 23 Apr 2007
Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
HSMN NewsFeed - 18 Apr 2007
FDA Confirms Mylan's Status as the Only Approved ANDA for all Strengths of Amlodipine Besylate Tablets
FDA Confirms Mylan's Status as the Only Approved ANDA for all Strengths of Amlodipine Besylate Tablets
HSMN NewsFeed - 18 Apr 2007
Schering-Plough Announces ZETIA Approved in Japan for Treatment of High Cholesterol
Schering-Plough Announces ZETIA Approved in Japan for Treatment of High Cholesterol
HSMN NewsFeed - 13 Apr 2007
Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
HSMN NewsFeed - 28 Mar 2007
Daiichi Sankyo, Inc. Announces Filing For WelChol Label Change to Include Ezetimibe Efficacy Data
Daiichi Sankyo, Inc. Announces Filing For WelChol Label Change to Include Ezetimibe Efficacy Data
HSMN NewsFeed - 27 Mar 2007
U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs
U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs
HSMN NewsFeed - 26 Mar 2007
Merck and Schering-Plough to Develop Another New Cholesterol Lowering Medicine
Merck and Schering-Plough to Develop Another New Cholesterol Lowering Medicine
HSMN NewsFeed - 26 Mar 2007
Mylan Announces Another First to Market With the Launch of Ciprofloxacin Extended-Release Tablets
Mylan Announces Another First to Market With the Launch of Ciprofloxacin Extended-Release Tablets
HSMN NewsFeed - 23 Mar 2007
Advancis Pharmaceutical Resubmits New Drug Application for Once-Daily Amoxicillin PULSYS
Advancis Pharmaceutical Resubmits New Drug Application for Once-Daily Amoxicillin PULSYS
HSMN NewsFeed - 14 Mar 2007
Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets
Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets
HSMN NewsFeed - 28 Feb 2007
Advancis Pharmaceutical Reaches Agreement with FDA for Resubmission of Amoxicillin PULSYS NDA
Advancis Pharmaceutical Reaches Agreement with FDA for Resubmission of Amoxicillin PULSYS NDA
HSMN NewsFeed - 26 Feb 2007
Mylan Announces Tentative FDA Approval for Ondansetron Orally Disintegrating Tablets, USP
Mylan Announces Tentative FDA Approval for Ondansetron Orally Disintegrating Tablets, USP
HSMN NewsFeed - 16 Feb 2007
Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
HSMN NewsFeed - 8 Feb 2007
Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
HSMN NewsFeed - 31 Jan 2007
Mylan Announces Tentative Approval for Valacyclovir Hydrochloride Tablets
Mylan Announces Tentative Approval for Valacyclovir Hydrochloride Tablets
HSMN NewsFeed - 30 Jan 2007
Mylan Announces Final FDA Approval for Albuterol Sulfate Extended-Release Tablets
Mylan Announces Final FDA Approval for Albuterol Sulfate Extended-Release Tablets
HSMN NewsFeed - 3 Jan 2007
Mylan's Levothyroxine Sodium Tablets USP Approved as Generic Equivalent to Levothroid(R)
Mylan's Levothyroxine Sodium Tablets USP Approved as Generic Equivalent to Levothroid(R)
HSMN NewsFeed - 26 Dec 2006
Par Pharmaceutical Receives Approval for Ondansetron Orally Disintegrating Tablets
Par Pharmaceutical Receives Approval for Ondansetron Orally Disintegrating Tablets
HSMN NewsFeed - 13 Nov 2006
Par Pharmaceutical Announces Agreement With GlaxoSmithKline to Settle Imitrex(R) Injection Patent Litigation
Par Pharmaceutical Announces Agreement With GlaxoSmithKline to Settle Imitrex(R) Injection Patent Litigation
HSMN NewsFeed - 13 Nov 2006
WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
HSMN NewsFeed - 13 Nov 2006
XOPENEX HFA(R) Data Presented at American College of Allergy, Asthma and Immunology Annual Meeting
XOPENEX HFA(R) Data Presented at American College of Allergy, Asthma and Immunology Annual Meeting
HSMN NewsFeed - 1 Nov 2006
IMS Health Names Bruce Boggs Senior Vice President, Global Marketing and External Affairs
IMS Health Names Bruce Boggs Senior Vice President, Global Marketing and External Affairs
HSMN NewsFeed - 18 Oct 2006
Santarus Licenses OTC Rights to Lower Dosage Immediate-Release ZEGERID Products to Schering-Plough
Santarus Licenses OTC Rights to Lower Dosage Immediate-Release ZEGERID Products to Schering-Plough
HSMN NewsFeed - 17 Oct 2006
ICOS Corporation Announces Agreement to be Acquired by Eli Lilly and Company
ICOS Corporation Announces Agreement to be Acquired by Eli Lilly and Company
HSMN NewsFeed - 13 Oct 2006
BioAlliance Pharma Receives Marketing Authorisation for Its First Product, Loramyc(R)
BioAlliance Pharma Receives Marketing Authorisation for Its First Product, Loramyc(R)
HSMN NewsFeed - 7 Sep 2006
King Pharmaceuticals Announces Strategic Acquisition of Avinza(R) from Ligand Pharmaceuticals
King Pharmaceuticals Announces Strategic Acquisition of Avinza(R) from Ligand Pharmaceuticals
HSMN NewsFeed - 7 Sep 2006
Watson Pharmaceuticals Receives FDA Final Approval for Generic Seasonale(R)
Watson Pharmaceuticals Receives FDA Final Approval for Generic Seasonale(R)
HSMN NewsFeed - 18 Jul 2006
AstraZeneca Submits NDA for Sustained Release Formulation of SEROQUEL(R) for Schizophrenia Treatment
AstraZeneca Submits NDA for Sustained Release Formulation of SEROQUEL(R) for Schizophrenia Treatment
HSMN NewsFeed - 1 Jun 2006
Advancis Pharmaceutical Completes Enrollment in Amoxicillin PULSYS Phase III Trial
Advancis Pharmaceutical Completes Enrollment in Amoxicillin PULSYS Phase III Trial
HSMN NewsFeed - 30 May 2006
Stiefel Laboratories Appoints Jim Loerop, Vice President U.S. Corporate Development
Stiefel Laboratories Appoints Jim Loerop, Vice President U.S. Corporate Development
HSMN NewsFeed - 22 May 2006
New Studies Examine SEROQUEL(R) in Combination With Antidepressant Therapy in Patients With Depression
New Studies Examine SEROQUEL(R) in Combination With Antidepressant Therapy in Patients With Depression
HSMN NewsFeed - 8 May 2006
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
Additional items found! 125
Members Archive contains
125 additional stories matching:
IMS Health
(Password required)
IMS Health
(Password required)
